MiMedx Group, Inc. Interest Income (Expense), Nonoperating, Net
MiMedx Group, Inc. (MDXG) reported Interest Income (Expense), Nonoperating, Net of $788.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-07-29
- MiMedx Group, Inc. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was $788.00K, a 6.78% increase year-over-year.
- MiMedx Group, Inc. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was $886.00K, a 75.10% increase year-over-year.
- MiMedx Group, Inc. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was $904.00K, a 124.32% increase year-over-year.
- MiMedx Group, Inc. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was $785.00K, a 182.37% increase year-over-year.
- MiMedx Group, Inc. interest income (expense), nonoperating, net for fiscal 2025 was $2.93M.
- MiMedx Group, Inc. interest income (expense), nonoperating, net for fiscal 2024 was -$1.01M.
- MiMedx Group, Inc. interest income (expense), nonoperating, net for fiscal 2023 was -$6.46M.
- MiMedx Group, Inc. interest income (expense), nonoperating, net for fiscal 2022 was -$5.02M.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $788.00K 10-Q · filed 2026-07-29 | $1.67M 10-Q · filed 2026-07-29 | $2.58M derived: sum of 3 quarters · filed 2026-07-29 | $3.36M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $886.00K 10-Q · filed 2026-04-29 | $1.79M derived: sum of 2 quarters · filed 2026-04-29 | $2.58M derived: sum of 3 quarters · filed 2026-04-29 | $3.31M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $904.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.69M derived: sum of 2 quarters · filed 2026-02-25 | $2.43M derived: sum of 3 quarters · filed 2026-07-29 | $2.93M 10-K · filed 2026-02-25 |
| 2025-09-30 | $785.00K 10-Q · filed 2025-10-29 | $1.52M derived: sum of 2 quarters · filed 2026-07-29 | $2.03M 10-Q · filed 2025-10-29 | $2.43M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $738.00K 10-Q · filed 2026-07-29 | $1.24M 10-Q · filed 2026-07-29 | $1.65M derived: sum of 3 quarters · filed 2026-07-29 | $1.93M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $506.00K 10-Q · filed 2026-04-29 | $909.00K derived: sum of 2 quarters · filed 2026-04-29 | $1.19M derived: sum of 3 quarters · filed 2026-04-29 | $1.19M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $403.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $681.00K derived: sum of 2 quarters · filed 2026-02-25 | $684.00K derived: sum of 3 quarters · filed 2026-02-25 | -$1.01M 10-K · filed 2026-02-25 |
| 2024-09-30 | $278.00K 10-Q · filed 2025-10-29 | $281.00K derived: sum of 2 quarters · filed 2025-10-29 | -$1.41M 10-Q · filed 2025-10-29 | -$3.00M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $3.00K 10-Q · filed 2025-07-30 | -$1.69M 10-Q · filed 2025-07-30 | -$3.28M derived: sum of 3 quarters · filed 2026-02-25 | -$4.96M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$1.69M 10-Q · filed 2025-04-30 | -$3.28M derived: sum of 2 quarters · filed 2026-02-25 | -$4.96M derived: sum of 3 quarters · filed 2026-02-25 | -$6.59M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$3.27M derived: sum of 2 quarters · filed 2026-02-25 | -$4.90M derived: sum of 3 quarters · filed 2026-02-25 | -$6.46M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$1.68M 10-Q · filed 2024-10-30 | -$3.31M derived: sum of 2 quarters · filed 2024-10-30 | -$4.86M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | -$1.63M 10-Q · filed 2024-07-31 | -$3.18M 10-Q · filed 2024-07-31 | ||
| 2022-12-31 | -$5.02M 10-K · filed 2025-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |